Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New study highlights misunderstanding surrounding risks and benefits of tamoxifen

22.03.2004


Use of tamoxifen by high risk women is low due to both failure of doctors to offer it and patients’ refusal to accept it, according to the results of a new study led by researchers at Northwestern Memorial Hospital. While tamoxifen chemoprevention has been shown to reduce the occurrence of breast cancer by nearly 50 percent in women with elevated risk, this study shows that the drug’s risks and benefits aren’t always appropriately evaluated when determining who should take it.



The study, which will be published March 22, 2004 in the online edition of CANCER, is the largest to date to review use of the drug in risk-eligible women.

"The study shows that doctors tend to offer tamoxifen to women who will reap the greatest benefit from the drug due to risk caused by certain types of benign breast disease and to those at lower risk of severe side effects. That makes sense," explains Monica Morrow, M.D., the study’s lead author and director of breast surgery at Northwestern Memorial Hospital. "What doesn’t make sense is that women significantly less likely to have side effects, such as premenopausal women and those without a uterus, did not accept tamoxifen more frequently than other groups." Dr. Morrow is also a professor of surgery at Northwestern University’s Feinberg School of Medicine.


"There clearly is a lot of confusion among women about the risks and benefits of tamoxifen chemoprevention," continues Dr. Morrow. "Our findings indicate a great deal of misunderstanding about tamoxifen’s risks and benefits among women, probably due to all the negative press it has gotten over the years. They also indicate that we need better educational strategies to help women make this decision."

Study researchers analyzed data from 219 women with increased breast cancer risk to identify clinical factors that would predict its use. Overall, only 63 percent of the women were offered tamoxifen and only 26 percent accepted. The authors conclude, "Our findings indicate that both physician practice and the attitudes of at risk women are responsible for low rates of tamoxifen usage."

The United States Food and Drug Administration approved tamoxifen in 1998 for breast cancer risk reduction in women with elevated breast cancer risk. The worldwide data showed an average 38 percent risk reduction in breast cancer for all risk-eligible women, although the largest U.S. trial showed a 49 percent reduction. Women with atypical hyperplasia (AH) or lobular carcinoma in situ (LCIS) derived the greatest benefit – e.g., an absolute risk reduction of 86 percent for women with AH in one study. Approximately 2.4 million women are estimated to be eligible to benefit from tamoxifen.


Article: "Acceptance of Tamoxifen Chemoprevention by Physicians and Women at Risk," Julia Tchou, Nanjiang, Hou, Alfred Rademaker, V. Craig Jordan, and Monica Morrow, CANCER; Published Online March 22, 2004; Print Issue Date: May 1, 2004.


About Northwestern Memorial Hospital

Northwestern Memorial Hospital (NMH) is one of the country’s premier academic medical centers and is the primary teaching hospital of Northwestern University’s Feinberg School of Medicine. Northwestern Memorial and its Prentice Women’s Hospital and Stone Institute of Psychiatry have 744 beds and more than 1,200 affiliated physicians and 5,000 employees. Providing state-of-the-art care, NMH is recognized for its outstanding clinical and surgical advancements in such areas as cardiothoracic and vascular care, gastroenterology, neurology and neurosurgery, oncology, organ and bone marrow transplantation, and women’s health.

Northwestern Memorial was ranked as the nation’s 5th best hospital by the 2002 Consumer Checkbook survey of the nation’s physicians and is listed in the majority of specialties in this year’s US News & World Report’s issue of "America’s Best Hospitals." NMH is also cited as one of the "100 Best Companies for Working Mothers" by Working Mother magazine and has been chosen by Chicagoans year after year as their "most preferred hospital" in National Research Corporation’s annual survey.

Patty Keiler | EurekAlert!
Further information:
http://www.nmh.org/

More articles from Health and Medicine:

nachricht 'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers
16.02.2018 | National University of Science and Technology MISIS

nachricht New process allows tailor-made malaria research
16.02.2018 | Eberhard Karls Universität Tübingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

'Lipid asymmetry' plays key role in activating immune cells

20.02.2018 | Life Sciences

MRI technique differentiates benign breast lesions from malignancies

20.02.2018 | Medical Engineering

Major discovery in controlling quantum states of single atoms

20.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>